How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

198,510 results for

Risk Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women

Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women - ACOG Menu ▼ Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous (...) Women Page Navigation ▼ Share: Practice Advisory: Clinical guidance for integration of the findings of The ARRIVE Trial: Labor Induction versus Expectant Management in Low-Risk Nulliparous Women This Practice Advisory has been endorsed by the Society for Maternal-Fetal Medicine. A randomized controlled trial comparing elective induction of labor at 39 weeks gestation with expectant management among low-risk nulliparous women was published in the on August 8, 2018 (1). The study was a large unmasked

2018 American College of Obstetricians and Gynecologists

22. Climate-resilient water safety plans: managing health risks associated with climate variability and change

Climate-resilient water safety plans: managing health risks associated with climate variability and change Climate-resilient water safety plans: managing health risks associated with climate variability and change JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Climate-resilient water safety plans: managing health risks associated with climate variability and change View/ Open (...) Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Climate-resilient water safety plans: managing health risks associated with climate variability and change. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description vi, 82 p. ISBN 9789241512794 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  Assemblée mondiale de la Santé, 51 (‎ A51/40 , 1998 )‎  World Health Assembly, 51 (‎ A51/40 , 1998

2017 WHO

23. Prevention and Management of Cardiovascular Disease Risk in Primary Care

Prevention and Management of Cardiovascular Disease Risk in Primary Care PEER SIMPLIFIED GUIDELINE: PREVENTION AND MANAGEMENT OF CARDIOVASCULAR DISEASE RISK IN PRIMARY CARE Clinical Practice Guideline | February 2015 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. OBJECTIVE Alberta primary care (...) clinicians and their teams offer primary and secondary prevention for cardiovascular disease (CVD) focused on CVD risk estimation and lipid management. TARGET POPULATION Men aged 40-75 Women aged 50-75 (optional start at age 40 for simplicity) EXCLUSIONS Men and women of any age with previously diagnosed familial hypercholesterolemia RECOMMENDATIONS ? Screen for CVD risk beginning at age 40 for men and 50 for women. PRACTICE POINT Always use a risk calculator with every lipid measurement to assess CVD

2016 Toward Optimized Practice

24. Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women

Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 36, Issue 9, Supplement 2, Pages S6–S15 Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women DOI: To view the full text, please login as a subscribed user or . Click to view the full (...) As outlined in the following chapters of this update to the Canadian Consensus Conference on Menopause 3 and the Canadian Consensus Conference on Osteoporosis, 4 many of the risk factors for the conditions prevalent among older women are modifiable through changes in lifestyle. To access this article, please choose from the options below Log In Register Purchase access to this article Claim Access If you are a current subscriber with Society Membership or an Account Number, . Subscribe to this title

2014 Society of Obstetricians and Gynaecologists of Canada

25. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

26. ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients

ESMO Consensus Conference on Malignant Lymphoma: Management of ?ultra-high-risk? Patients SPECIAL ARTICLE ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients M. Hutchings 1 * , M. Ladetto 2 , C. Buske 3 , P. de Nully Brown 1 , A. J. M. Ferreri 4 , M. Pfreundschuh 5† , N. Schmitz 6 , A. Sureda Balari 7 , G. van Imhoff 8 , J. Walewski 9 & the ESMO Lymphoma Consensus Conference Panel Members ‡ 1 Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 2 (...) poorly to therapy and eventually die from their disease. A number of clinical and pathological factors de?ne groups of patients who are at very high risk of such treatment failure. For these ‘ultra-high-risk’ patients, there is no international consensus regarding the opti- mal management approach. In 2015, the European Society for Medical Oncology (ESMO) held a consensus conference on malignant lymphoma in order to develop recommendations on critical subjects that were dif?cult to consider in detail

2018 European Society for Medical Oncology

27. CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery

CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 33, Issue 1, Pages 17–32 Canadian Cardiovascular Society Guidelines on Perioperative Cardiac (...) Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery x Emmanuelle Duceppe Affiliations Department of Medicine, University of Montreal, Montreal, Quebec, Canada Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada , MD a , b , c , x Joel Parlow Affiliations Department of Anesthesiology and Perioperative Medicine

2016 Canadian Cardiovascular Society

28. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. (PubMed)

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. With recent changes in UK clinical practice for diabetes care, contemporary estimates of sex disparities in cardiovascular risk and risk factor management are needed.In this retrospective cohort study, using the Clinical Practice Research Datalink linked to hospital and death records for people in England, we identified 79,985 patients with incident T2DM between 2006 (...) -2013 matched to 386,547 patients without diabetes. Sex-stratified Cox models were used to assess cardiovascular risk.Compared to women without T2DM, women with T2DM had a higher cardiovascular event risk (adjusted HR 1.20 [95% CI 1.12-1.28]) with similar corresponding data in men (HR 1.12 [1.06-1.19]) leading to a non-significant higher relative risk in women (risk ratio 1.07 [0.98-1.17]). However, some important sex differences in the management of risk factors were observed. Compared to men

2019 Circulation

29. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i> breast cancer families. (PubMed)

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families. The currently known breast cancer-associated single nucleotide polymorphisms (SNPs) are presently not used to guide clinical management. We explored whether a genetic test that incorporates a SNP-based polygenic risk score (PRS) is clinically meaningful in non-BRCA1/2 high-risk breast cancer families.101 non-BRCA1/2 high-risk breast (...) Excellence and the Netherlands (Netherlands Comprehensive Cancer Organisation), respectively.Our results support the application of the PRS in risk prediction and clinical management of women from genetically unexplained breast cancer families.© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

2019 Journal of Medical Genetics

30. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department The Ottawa chronic obstructive pulmonary disease (COPD) Risk Scale (OCRS), which consists of 10 criteria, was previously derived to identify patients in the emergency department with COPD who were at high risk for short-term serious outcomes. We sought to validate, prospectively and explicitly, the OCRS when applied by physicians in the emergency (...) department.We conducted this prospective cohort study involving patients in the emergency departments at 6 tertiary care hospitals and enrolled adults with acute exacerbation of COPD from May 2011 to December 2013. Physicians evaluated patients for the OCRS criteria, which were recorded on a data form along with the total risk score. We followed patients for 30 days and the primary outcome, short-term serious outcomes, was defined as any of death, admission to monitored unit, intubation, noninvasive

Full Text available with Trip Pro

2019 EvidenceUpdates

31. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. (PubMed)

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population.A representative sample of 57 779 adults aged 20 years or older was recruited (...) . Asthma was determined on the basis of a self-reported history of diagnosis by a physician or by wheezing symptoms in the preceding 12 months. All participants were assessed with a standard asthma questionnaire and were classed as having or not having airflow limitation through pulmonary function tests before and after the use of a bronchodilator (400 μg of salbutamol). Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants for whom data on the variables

2019 Lancet

32. Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. (PubMed)

Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. In May 2019, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved an update to the 2013 joint clinical practice guideline for assessing and managing patients who are at risk for suicide. This guideline provides health care providers with a framework by which to screen for, evaluate (...) , treat, and manage the individual needs and preferences of VA and DoD patients who may be at risk for suicide.In January 2018, the VA/DoD Evidence-Based Practice Work Group convened to develop a joint VA/DoD guideline including clinical stakeholders and conforming to the National Academy of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel drafted key questions, systematically searched and evaluated the literature through April 2018, created algorithms, and advanced

2019 Annals of Internal Medicine

33. Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial

Efficacy of a Home Visiting Enhancement for High-Risk Families Attending Parent Management Programs: A Randomized Superiority Clinical Trial Antisocial behavior and adult criminality often have origins in childhood and are best addressed early in the child's life using evidence-based parenting programs. However, families with additional risk factors do not always make sufficient changes while attending such programs; these families may benefit from additional support.To evaluate the efficacy (...) of adding a 10-session, structured home parent support (HPS) intervention to enhance outcomes for high-risk families attending the Incredible Years Parent (IYP) program.A randomized clinical superiority trial of 126 parents of children aged 3 to 7 years with conduct problems compared the IYP program plus HPS with treatment as usual of the IYP program alone. Child behavior measures were collected before and after treatment and at the 6-month follow-up. Recruitment from 19 IYP groups began February 13

2019 EvidenceUpdates

34. Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide

Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links (...) Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide, Version 1.1 No Thumbnail View/ Open View Statistics Altmetrics Share Citation World Health Organization & Food and Agriculture Organization of the United Nations . (‎2016)‎. Microbiological criteria and sampling plan analysis tool: companion tool to Statistical aspects of microbiological criteria related to foods: a risk managers guide, Version

2016 WHO

35. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR.0000000000000450 December 6, 2016 e535 CLINICAL STATEMENTS AND GUIDELINES T he comorbidities of hypertension, diabetes mellitus, obesity, hyperlipidemia, and metabolic syndrome are common in patients with heart failure (HF (...) of overweight and obesity 6 in the general population and in patients with increased cardiovascular risk, and a recent report from the Eighth Joint Na- tional Committee addressed the management of hypertension. 7 However, these guidelines did not specifically address the management of such comorbidities in patients with HF. Similarly, the most recent ACCF/AHA HF practice guidelines 8 in 2013 addressed the overall management of comorbidities in patients with HF in broad terms, but again, specific

Full Text available with Trip Pro

2016 American Heart Association

36. An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services

An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please (...) choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} An evidence synthesis of risk identification, assessment and management for young people using tier 4 inpatient child and adolescent mental health services {{author}} {{($index , , , , , & . Ben Hannigan 1, * , Deborah Edwards 1 , Nicola Evans 1 , Elizabeth Gillen 2 , Mirella Longo 3 , Steven Pryjmachuk

Full Text available with Trip Pro

2015 NIHR HTA programme

37. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. (PubMed)

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80%; however, improving longer-term outcomes remains a challenge. Improving the function of grafts and health of recipients would (...) not only enhance quality and length of life, but would also reduce the need for retransplantation, and thus increase the number of organs available for transplant. The clinical transplant community needs to identify and manage those patient modifiable factors, to decrease the risk of graft failure, and improve longer-term outcomes.COMMIT was formed in 2015 and is composed of 20 leading kidney and liver transplant specialists from 9 countries across Europe. The group's remit is to provide expert

Full Text available with Trip Pro

2017 Transplantation

38. Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers (PubMed)

Risk Assessment of Histamine in Chilled, Frozen, Canned and Semi-Preserved Fish in Morocco; Implementation of Risk Ranger and Recommendations to Risk Managers A risk assessment of histamine was conducted for different categories of fishery products in the market. Risk estimates were assessed using the Risk Ranger tool. The estimated risks associated with the consumption of canned, semi-preserved and frozen fish are lower than those associated with fresh fish. According to the hypotheses (...) , it ranges from zero to 21. For canned fish, the risk ranking varies between 12 (five patients for 1000 years) and 21 (15 patients for 100 years). As a result, most Moroccan seafood products are classified as "low risk". However, it is recommended that risk managers maintain the adopted measures, strengthen interventions upstream in the food chain and that professionals maintain the HACCP (Hazard Analysis Critical Control Point) system effectively.

Full Text available with Trip Pro

2018 Foods

39. CVD risk assessment and management

CVD risk assessment and management CVD risk assessment and management - NICE CKS Share CVD risk assessment and management: Summary Cardiovascular disease (CVD) is an umbrella term that describes a range of conditions that affect the heart, the blood vessels, or both. It is caused by blood clots (thrombosis), or atherosclerosis. CVD is a significant cause of mortality and morbidity, accounting for almost a quarter of all deaths in the UK. In 2016, CVD caused 21% of premature deaths (deaths (...) modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease [ ], the Public Health England (PHE) NHS Health Check: best practice guidance [ ], the European Society of Cardiology (ESC) 2016 European guidelines on cardiovascular disease prevention in clinical practice [ ], and a handbook commissioned by the UK National Screening Committee The Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management

2019 NICE Clinical Knowledge Summaries

40. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y

Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-y Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk

2014 NIHR HTA programme

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>